Human peritoneal fibroblast proliferation in 3-dimensional culture: Modulation by cytokines, growth factors and peritoneal dialysis effluent

Kidney International

Volumn 51, Issue 1, 1997, Pages 205-215

  Beavis, M Janine ^b   Williams, John D ^b   Hoppe, Jürgen ^b   Topley, Nicholas ^a  

^a Cardiff Royal Infirmary   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GROWTH FACTOR; PERITONEAL DIALYSIS FLUID;

ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; FIBROBLAST CULTURE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCYTOCHEMISTRY; PERITONEUM; PRIORITY JOURNAL;

EID: 0031058833     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.25     Document Type: Article

References (74)

1. HEIMBÜRGER O, WANIEWSKI J, WERYNSKI A, TRANAEUS A, LINDHOLM B: Peritoneal transport in CAPD patients with permanent loss of ultrafiltration capacity. Kidney Int 38:495-506, 1990
2. GANDHI VC, HUMAYUN HM, ING TS, DAUGIRDAS JT, JABLOKOW VR, IWATSUKI S, GEIS WP, HANO JE: Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 140:1201-1203, 1980
3. DI PAOLO N, SACCHI G, DE MIA M, GAGGIOTTI E, CAPOTONDO L, ROSSI P, BERNINI M, PUCCI A, SABATELLI P, ALESSANDRINI C: Morphology of the peritoneal membrane during continuous ambulatory peritoneal peritoneal dialysis. Nephron 44:204-211, 1986
4. RUBIN J, HERRARA GA, COLLINS D: An autopsy study of the peritoneal cavity from patients on continuous ambulatory peritoneal dialysis. Am J Kid Dis 17:97-102, 1991
5. DOBBIE J, ZAKI M, WILSON L: Ultrastructural studies on the peritoneum with special reference to chronic ambulatory peritoneal dialysis. Scott Med J 26:213-223, 1981
6. VERGER C, BRUNSCHVICG O, CHARPENTIER YL, LAVERGNE A, VANTELON J: Structural and ultrastructural peritoneal membrane changes and permeability alterations during continuous ambulatory peritoneal dialysis. Proc Eur Dial Transplant Assoc 18:199-205, 1981
7. GOTLOIB L, BAR-SELLA P, SHOSTAK A: Reduplicated basal lamina of small venules and mesothelium of human parietal peritoneum: Ultrastructural changes of reduplicated peritoneal basement membrane. Perit Dial Bull 5:212-214, 1985
8. DOBBIE J, LLOYD J, GALL C: Categorization of ultrastruclural changes in peritoneal mesothelium, stroma and blood vessels in uremia and CAPD patients. Perit Dial Int 1990, pp 3-12
9. SLATER ND, COPE GH, RAPTERY AT: Mesothelial hyperplasia in response to peritoneal dialysis fluid: A morphometric study in the rat. Nephron 58:466-471, 1991
10. FREUNDLICH B, BOMALASKI JS, NEILSON E, JIMINEZ SA: Regulation of fibroblast proliferation and collagen synthesis by cytokines. Immunol Today 7:303-307, 1986
11. KUNICO GS, NEILSON EG, HAVERTY T: Mechanisms of tubulointerstitial fibrosis. Kidney Int 39:550-556, 1991
12. MAUCH C, KRIEG T: Fibroblast-matrix interactions and their role in the pathogenesis of fibrosis. Rheumatic Dis Clin N Am 16:93-107, 1990
13. WAHL SM: Fibrosis: Bacterial cell wall induced hepatic granulomas, in Basic Principles and Clinical Correlates, edited by GALLIN JI, GOLDSTEIN IM, SNYDERMAN R, New York, Raven Press, 1988, pp 841-859
14. PELTONEN J, KÄHÄRI L, JAAKKOLA S, KÄHÄRI VM, VARGA J, UITTO J, JIMINEZ SA: Evaluation of transforming growth factor-β and type 1 procollagen gene expression in fibrotic skin diseases by in situ hybridisation. J Invest Dermatol 94:365-371, 1990
15. KORN JH, HALUSHKA PV, LEROY EC: Mononuclear cell modulation of connective tissue function: Suppression of fibroblast growth by stimulation with endogenous prostaglandin production. J Clin Invest 65:543-554, 1980
16. BITTERMAN PB, RENNARD SI, HUNNINGHAKE GW, CRYSTAL RG: Human alveolar macrophage growth factor for fibroblasts: Regulation and partial characterisation. J Clin Invest 70:806-822, 1982
17. LESLIE CC, MUSSON RA, HENSON PM: Production of growth factor activity for fibroblasts by human monocyte derived macrophages. J Leuk Biol 36:143-159, 1984
18. ESTES JE, PLEDGER WJ, GILLESPIE GY: Macrophage derived growth factor for fibroblasts and interleukin-1 are distinct entities. Leuk Biol 35:115-129, 1984
19. WHITESIDE TL, WORRALL JG, PRINCE RK, BUCKINGHAM RG, RODMAN GP: Soluble mediators from mononuclear cells increase the synthesis of glycosaminoglycan by dermal fibroblast cultures derived from normal subjects and progressive systemic sclerosis patients. Arthritis Rheum 28:188-197, 1985
20. POSTLETHWAITHE AE, SNYDERMAN R, KANG AH: The chemotactic attraction of human fibroblasts to a lymphocyte-derived factor. J Exp Med 144:1188-1203, 1976
21. POSTLETHWAITHE AE, SEYER JM, KANG AH: Chemotactic attraction of human fibroblasts to type I, II and III collagen and collagen-derived peptides. Proc Natl Acad Sci USA 75:871, 1978
22. SUASSUNA JHR, DAS NEVES FC, HARTLEY RB, OGG, CS, CAMERON JS: Immunohistochemical studies of the peritoneal membrane and infiltrating cells in normal subjects and in patients on CAPD. Kidney Int 46:443-454, 1994
23. BETJES MGH, TUK CW, STRUIJK DG, KREDIET RT, ARISZ L, HART M, BEELEN RH: Interleukin-8 production by human peritoneal mesothelial cells in response to tumor necrosis factor α, interleukin-1, and medium conditioned by macrophages co-cultured with Staphylococcus epidermidis. J Inf Dis 168:1202-1210, 1993
24. DOUVDEVANI A, RAPOPORT J, KONFORTY A, ARGOV S, OVNAT A, CHAIMOWITZ C: Human peritoneal mesothelial cells synthesisze IL-1α and -β. Kidney Int 46:993-1001, 1994
25. TOPLEY N, JÖRRES A, LUTTMANN W, PETERSEN M, LANG M, THIERAUSCH K-H, MÜLLER C, COLES G, DAVIES M, WILLIAMS J: Human peritoneal mesothelial cells synthesize IL-6: Induction by IL-β and TNFα. Kidney Int 43:226-233, 1993
26. TOPLEY N, BROWN Z, JÖRRUS A, WESTWICK J, COLES GA, DAVIES M, WILLIAMS JD: Human peritoneal mesothelial cells synthesize IL-8: Synergistic induction by interleukin-1β and tumor necrosis factor α. Am J Pathol 142:1876-1886, 1993
27. TOPLEY N, PETERSEN MM, MACKENZIE R, KAEVER V, NEUBAUER A, STYLIANOU E, COLES GA, DAVIES M, JÖRRES A, WILLIAMS JD: Human peritoneal mesothelial cell prostaglandin synthesis: Induction of cyclooxygenase mRNA by peritoneal macrophage derived cytokines. Kidney Int 46:900-909, 1994
28. TOPLEY N, WILLIAMS JD: The role of the peritoneal membrane in the control of inflammation in the peritoneal cavity. Kidney Int 46(Suppl 48):S71-S78, 1994
29. GOODMAN RB, WOOD RG, MARTIN TR, HANSON PO, KINASEWITZ GT: Cytokine-stimulated human mesothelial cells produce chemotactic activity for neutrophils including NAP-1/IL-8. J Immunol 148:457-465, 1992
30. BOYLAN AM, RÜEGG C, JIN KK, HEBERT C, HOEFFEL JM, PYETELA R, SHEPPARD D, GOLDSTEIN IM, BROADDUS VC: Evidence of a role for mesothelial cell-derived interleukin 8 in the pathogenesis of asbestos-induced pleurisy in rabbits. J Clin Invest 89:1257-1267, 1992
31. HYNES RO: Integrins: Versatility, modulation, and signaling in cell adhesion. Cell 69:11-25, 1992
32. GAUSS-MÜLLER V, KLEINMAN HK, MARTIN GR, SCHIFFMANN E: Role of attachment factors and attractants in fibroblast chemotaxis. J Lab Clin Med 96:1071-1080, 1980
33. PANAYOTOU G, END P, AUMAILLEY M, TIMPI R, ENGEL J: Domains of laminin with growth factor activity. Cell 56:93-101, 1989
34. WEINBERG CB, BELL E: Regulation of proliferation of bovine aortic endothclial cells, smooth muscle cells and adventitial fibroblasts in collagen lattices. J Cell Physiol 122:410-414, 1985
35. HOPPE J, WEICH HA, EICHNER W: Preparation of biologically active PDGF-BB from a fusion protein expressed in E coli. Biochemistry 28:2956-2964, 1989
36. HOPPE J, WEICH HA, EICHNER W, TATIE D: Preparation of biologically active PDGF-AA and -AB. Preferential formation of PDGF-AB heterodimers. Eur J Biochem 187:207-213, 1990
37. STYLIANOU E, JENNER LA, DAVIES M, COLES GA, WILLIAMS JD: Isolation, culture and characterisation of human peritoneal mesothelial cells. Kidney Int 37:1563-1570, 1990
38. 14C]acetylated collagen. Analyt Biochem 99:340-345, 1979
39. MADRI JA, PRATT BM, TUCKER AM: Phenotypic modulation of endothelial cells by transforming growth factor-β depends upon the composition and organisation of the extracellular matrix. J Cell Biol 106:1375-1384, 1988
40. KISSANE JM, ROBINS E: The fluorimetric measurement of DNA in animal tissues with special reference to the central nervous system. J Biol Chem 233:184-188, 1958
41. REDINBAUGH MG, CAMPBELL WH: Adaptation of the dye-binding protein assay to microtitre plates. Anal Biochem 147:144-151, 1985
42. JÖRRES A, TOPLEY N, STEENWEG L, MÜLLER C, KÖTTGEN E, GAHL GM: Inhibition of cytokine synthesis by peritoneal dialysate persists throughout the CAPD cycle. Am J Nephrol 12:80-85, 1992
43. WITOWSKI J, JÖRRES A, WILLIAMS JD, TOPLEY N: Superinduction of IL-6 synthesis in human peritoneal mesothelial cells (HPMC): Stabilisation of mRNA by peritoneal dialysis effluent (PDE) and inflammatory cytokines. (abstract) J Am Soc Nephrol 6:568, 1995
44. MACKENZIE RK, COLES GA, WILLIAMS JD: Eicosanoid synthesis in human peritoneal macrophages stimulated with S. epidermidis. Kidney Int 37:1316-1324, 1990
45. MACKENZIE RK, COLES GA, WILLIAMS JD: The response of human peritoneal macrophages to stimulation with bacteria isolated from episodes of continuous ambulatory peritoneal dialysis-related peritonitis. J Infect Dis 163:837-842, 1991
46. MACKENZIE R, COLES GA, TOPLEY N, POWELL WS, WILLIAMS JD: Down regulation of cyclooxygenase product generation by human peritoneal macrophages. Immunol 76:648-654, 1992
47. WITOWSKI J, TOPLEY N, JÖRRES A, LIBEREK T, COLES GA, WILLIAMS JD: Effect of lactate buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 47:282-293, 1995
48. DAVIES SJ, BRYAN J, PHILLIPS L, RUSSELL GI: Longitudinal changes in peritoneal kinetics: The effects of peritoneal dialysis and peritonitis. Nephrol Dial Transplant 11:498-506, 1996
49. ZEMEL D, IMHOLZ ALT, DE WART DR, DINKLA C, STRUIJK DG, KREDIET RT: The appearance of tumor necrosis factor-α and soluble TNF-receptors I and II in peritoneal effluent during stable and infectious CAPD. Kidney Int 46:1422-1430, 1994
50. MOUTABARRIK A, NAKANISHI I, NAMIKI M, TSUBAKIHARA Y: Interleukin-1 and its naturally occurring inhibitor in peritoneal dialysis patients. Clin Nephrol 43:243-248, 1995
51. STEINHAUER HB, SCHOLLMEYER P: Prostaglandin mediated loss of proteins during peritonitis in continuous ambulatory peritoneal dialysis. Kidney Int 29:584-590, 1986
52. YUNG S, COLES GA, WILLIAMS JD, DAVIES M: The source and possible significance of hyaluronan in the peritoneal cavity. Kidney Int 46:527-533, 1994
53. GOLDMAN M, VANDENABEELE P, MOULART J, AMRAOUI Z, ABRAMOWICZ D, NORTIER J, VANHERWEGHEM JL, FIERS E: Intraperitoneal secretion of interleukin-6 during continuous ambulatory peritoneal dialysis. Nephron 56:277-280, 1990
54. BRAUNER A, HYLANDER B, WRETLIND B: Interleukin-6 and interleukin-8 in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kid Dis 22:430-435, 1993
55. WITOWSKI J, JÖRRES A, WILLIAMS JD, TOPLEY N: Superinduction of IL-6 synthesis in human peritoneal mesothelial cells is related to induction and stabilization of IL-6 mRNA. Kidney Int 50:1212-1223, 1996
56. ZEMEL D, KOOMEN GCM, HART AAM, TEN BERGE RJM, STRUIJK DG, KREDIET RT: Relationship of TNFα, interleukin-6, and prostaglandins to peritoneal permeability for macromolecules during longitudinal follow-up of peritonitis in continuous ambulatory peritoneal dialysis. J Lab Clin Med 122:686-696, 1994
57. SAPPINO AP, SCHÜRCH A, GABBIANI G: Differentiation repertoire of fibroblastic cells: Expression of cytoskeletal proteins as markers of phenotypic modulations. Lab Invest 63:144-161, 1990
58. ELSDALE T, BARD J: Collagen substrata for studies on cell behaviour. J Cell Biol 54:626-637, 1972
59. QWARNSTRÖM EE, MACFARLANE SA, PAGE RC, WIGHT TN: Effects of interleukin-1 on fibroblast extracellular matrix, using a 3-dimensional culture system. J Cell Physiol 139:501-508, 1989
60. SCHOR SL: Cell proliferation and migration on collagen substrata in vitro. J Cell Sci 41:159-175, 1980
61. GREVE H, BLUMBERG P, SCHMIDT G, SCHLUMBERGER W, RAUTERBERG J, KRESSE H: Influence of collagen lattice on the metabolism of small proteoglycan II by cultured fibroblasts. Biochem J 269:149-155, 1990
62. MAUCH C, HATAMACHI A, SCHARFFETTER K, KREIG T: Regulation of collagen synthesis in fibroblasts within a three-dimensional collagen gel. Exp Cell Res 178:493-503, 1988
63. HATAMOCHI A, AUMAILLEY M, MAUCH C, CHU M-L, TIMPL R, KRIEG, T: Regulation of collagen VI expression in fibroblasts: Effects of cell density, cell matrix interactions, and chemical transformation. J Biol Chem 264:3494-3499, 1989
64. QWARNSTRÖM EE, KINSELLA MG, MACFARLANE SA, PAGE RC, WIGHT TN: Modulation of proteoglycan metabolism by human fibroblasts maintained in an endogenous three-dimensional matrix. Eur J Cell Biol 57:101-108, 1992
65. FRIES KM, BLIEDEN T, LOONEY RJ, SEMPOWSKI GD, SILVERA MR, WILLIS RA, PHIPPS RP: Evidence for fibroblast heterogeneity and the role of fibroblast sub-populations in fibrosis. Clin Immunol Immunopathol 72:283-292, 1994
66. KOVACS EJ: Fibrogenic cytokines: The role of immune mediators in the development of scar tissue. Immunol Today 12:17-23, 1991
67. LONNEMANN G, SHAPIRO L, ENGLER-BLUM G, MÜLLER GA, KOCH KM, DINARELLO CA: Cytokines in human renal interstitial fibrosis. I. Interleukin-1 is a paracrine growth factor for cultured fibrosis-derived kidney fibroblasts. Kidney Int 47:837-844, 1995
68. ELIAS JA, FREUNDLICH B, KERN JA, ROSENBLOOM J: Cytokine networks in the regulation of inflammation and fibrosis in the lung. Chest 97:1439-1445, 1990
69. RAINES EW, DOWER SK, ROSS R: Interleukin-1 mitogenic activity for fibroblasts and smooth muscle cells is due to PDGF-AA. Science 243:393-396, 1989
70. FLOEGE J, ENG E, YOUNG BA, ALPERS CE, BARRETT TB, BOWEN-POPE DF, JOHNSON RJ: The infusion of PDGF or Basic FGF induces selective glomerular mesangial cell proliferation and matrix accumulation in rats. J Clin Invest 92:2952-2962, 1993
71. BURGESS WH, MACIAG T: The heparin-binding (fibroblast) growth factor family. Annu Rev Biochem 58:575-606, 1989
72. RAINES EW, BOWEN-POPE DF, Ross R: Platelet-derived growth factor, in Peptide Growth Factors and Their Receptors, edited by SPORN MB, ROBERTS AB, Heidelburg, Springer Verlag, 1989, pp 173-262
73. SELGAS R, LOPEZ-RIVAS A, MIRANDA B, MUNOZ C, RINON C, BORREGO F, MOLINA S, SANCHEZ-SICILIA L: Characterisation of the mitogenic-induced capacity of peritoneal effluent on human and mouse fibroblasts in culture. Nephrol Dial Transplant 6:44-50, 1991
74. BRAUNER A, HYLANDER B, WRETLIND B: Tumor necrosis factor-α, interleukin-1β, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 27:402-408, 1996